Latest Breaking News On - Sai life sciences - Page 1 : comparemela.com

Drug Metabolism And Pharmacokinetics (Dmpk) Market Size, Share Projected to Grow at 8 3% CAGR, Cross

Drug Metabolism And Pharmacokinetics (Dmpk) Market Size, Share Projected to Grow at 8 3% CAGR, Cross
pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.

United statesNew yorkPharmacokinetics dmpkAsia pacificLawrence johnPrudour pvt ltdExpansion of drug development pipelineDrug development activitiesSai life sciencesRising drug development activitiesHangzhou tigermed consulting coBiopharmaceutical companiesGlobal drug metabolism and pharmacokineticsDrug metabolism and pharmacokineticsAnalytical technologiesPersonalized medicine

Bharti Hexacom anchors Rs 1,924 cr from investors before IPO opens on April 3

The Bharti Hexacom IPO opens for subscription on April 3, with a price band at Rs 542-570 per share, and closes on April 5.

North carolinaUnited statesAbu dhabiAbuz abyUnited arab emiratesBharti infratelAditya birla sunBharti airtelBharti hexacomPrudential mutual fundPrudential life insurance companyAxis mutual fundMutual fundSmallcap world fundBharti groupSai life sciences

SRM Contractors closes at upper circuit, jumps 12 5% on debut

SRM Contractors shares traded in trade-for-trade segment, hence there is a 5 percent upper and lower circuit.

Jammu and kashmirSai life sciencesSrm contractors share priceSrm contractors stock priceSrm contractors nse priceSrm contractors bse price

Daily Voice: No rate cut before second half of FY25, says Anil Rego

The Right Horizons founder says Indian companies saw more upgrades than downgrades in the previous two quarters despite challenges and the earnings momentum is likely to continue in FY25

Bharti hexacomSai life sciencesCapital groupMonetary policy committeeAnil regoBright horizons

TPG-backed Sai Life Sciences picks 4 I-banks; to soon kick off Rs 5,000 cr-Rs 5,500 cr IPO

Before switching to the listing route, TPG-backed Sai Life Sciences had explored the sale of a controlling stake in the firm and conducted a sale process, which resulted in Bain Capital emerging as the front-runner in the final leg, according to a January 25 report by Moneycontrol. But talks between both parties did not fructify into a deal

Andhra pradeshUnited kingdomStelis biopharmaCohance lifesciencesKrishna kanumuriSai life sciences is syngeneSai life sciencesAragen life sciencesAdvent internationalMorgan stanleyGoldman sachsSuven pharmaceuticalsKotak mahindra capitalEquity indiaBain capitalSai life